Editorial comment

Affiliations

¹ Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD; Basic Science Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD.
² Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.

Editorial

Laura S Schmidt et al. Urology. 2014 Mar.

. 2014 Mar;83(3):675.e5; discussion 675.e5-6.

doi: 10.1016/j.urology.2013.09.070.

¹ Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD; Basic Science Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD.
² Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.

No abstract available

Comment on

Higher prevalence of novel mutations in VHL gene in Chinese Von Hippel-Lindau disease patients.
Wang X, Zhang N, Ning X, Li T, Wu P, Peng S, Fan Y, Bu D, Gong K. Wang X, et al. Urology. 2014 Mar;83(3):675.e1-5. doi: 10.1016/j.urology.2013.09.069. Urology. 2014. PMID: 24581539

1. [last updated 5/17/13]; http://www.genomed.org/lovd2/home.php?select_db=VHL.
1. Wu P, Zhang N, Wang X, et al. Family history of von Hippel-Lindau disease was uncommon in Chinese patients: suggesting the higher frequency of de novo mutations in VHL gene in these patients. J. Human Genet. 2012;57:238–243. - PubMed
1. Sgambati MT, Stolle C, Choyke PL, et al. Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents. Am. J. Hum. Genet. 2000;66:84–91. - PMC - PubMed